Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib in Metastatic Hormone Refractory Prostate Cancer After Docetaxel
NCT00748358Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Mar 2008
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in prostate cancer (PCa), sponsored by Assistance publique - Hôpitaux de Paris. Started Mar 2008; status: completed.
02
Drugs
sunitinib
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00748358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00748358.